Research ArticleTechnology/Application
The Implications of Chromatographically Screening Medical Products for Organic Leachables Down to the Analytical Evaluation Threshold Adjusted for Response Factor Variation
Dennis Jenke and Ted Heise
PDA Journal of Pharmaceutical Science and Technology May 2021, 75 (3) 273-288; DOI: https://doi.org/10.5731/pdajpst.2020.012013
Dennis Jenke
1Triad Scientific Solutions, LLC, Hawthorn Woods, IL; and
Ted Heise
2MED Institute Inc, West Lafayette, IN

References
- 1.↵Product Quality Research Institute. Safety Thresholds and Best Practices for Extractables and Leachables In Orally Inhaled and Nasal Drug Products, 2006. PQRI Web site. http://pqri.org/wp-content/uploads/2015/08/pdf/LE_Recommendations_to_FDA_09-29-06.pdf (accessed March 7, 2021).
- 2.↵International Conference for Harmonisation, Quality Guideline M7(R1): Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk. ICH: Geneva, 2015.
- 3.↵
- Mellon D
- 4.↵International Organization for Standardization, ISO/TS 21726:2019 Biological Evaluation of Medical Devices—Application of the Threshold of Toxicological Concern (TTC) for Assessing Biocompatibility of Medical Device Constituents. ISO: Geneva, 2019.
- 5.↵
- Norwood D. L.,
- Nagao L. M.
- 6.↵
- Jordi M. A.,
- Khera S.,
- Roland K.,
- Jiang L.,
- Solomon P.,
- Nelson J.,
- Lateef S. S.,
- Woods J.,
- Martin L.,
- Martin S.,
- Aiello F.,
- Chen N.
- 7.↵International Organization for Standardization, ISO 10993-18:2020 Biological Evaluation of Medical Devices—Part 18: Chemical Characterization of Medical Device Materials Within A Risk Management Process. ISO: Geneva, 2020.
- 8.↵
- Mullis J. O.,
- Granger A.,
- Quin C.,
- Norwood D. L.
- 9.
- Jenke D.,
- Odufu A.
- 10.↵
- Zdravkovic S. A.,
- Duong C. T.,
- Hellenbrand A. A.,
- Duff S. R.,
- Dreger A. L.
- 11.↵
- Christiaens P.,
- Beusen J. M.,
- Verlinde P.,
- Baeten J.,
- Jenke D.
- 12.↵
- Jordi M. A.,
- Rowland K.,
- Liu W.,
- Cao X.,
- Zong J.,
- Ren Y.,
- Liang Z.,
- Zhou X.,
- Louis M.,
- Lerner K.
- 13.↵
- Jenke D.,
- Liu N.
- 14.↵
- Zdravkovic S.,
- Bruss M. D.,
- Piccoli R. F.,
- Wood D. M.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 75, Issue 3
May/June 2021
The Implications of Chromatographically Screening Medical Products for Organic Leachables Down to the Analytical Evaluation Threshold Adjusted for Response Factor Variation
Dennis Jenke, Ted Heise
PDA Journal of Pharmaceutical Science and Technology May 2021, 75 (3) 273-288; DOI: 10.5731/pdajpst.2020.012013
The Implications of Chromatographically Screening Medical Products for Organic Leachables Down to the Analytical Evaluation Threshold Adjusted for Response Factor Variation
Dennis Jenke, Ted Heise
PDA Journal of Pharmaceutical Science and Technology May 2021, 75 (3) 273-288; DOI: 10.5731/pdajpst.2020.012013
Jump to section
- Article
- Abstract
- Introduction: Extractables, Leachables, and the Analytical Evaluation Threshold
- Problem Statement: The Analytical Evaluation Threshold Gap
- Filling the Analytical Evaluation Threshold Gap with the Uncertainty Factor
- Current Practice with Regard to Establishing the Magnitude of the Uncertainty Factor
- Issues with the Use of Large Uncertainty Factors to Adjust the Analytical Evaluation Threshold
- Managing the Uncertainty Adjustment
- Conclusion
- Conflict of Interest Declaration
- References
- Figures & Data
- References
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- Addressing Medical Device Extractables and Leachables via Non-Target Analysis (NTA); The Analytical Evaluation Threshold (AET) and Quantitation
- Standardization of Chromatographic Screening Methods for Organic Extractables and Leachables by Managing Outcomes
- A Practical Derivation of the Uncertainty Factor Applied to Adjust the Extractables/Leachables Analytical Evaluation Threshold (AET) for Response Factor Variation